Profile data is unavailable for this security.
About the company
BIOLASE, Inc. is a medical device company that develops, manufactures, markets and sells laser systems in dentistry and medicine. The Company's systems allow dentists, periodontists, endodontists, pediatric dentists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. It offers two categories of laser system products: Waterlase (all-tissue) systems and diode (soft-tissue) systems. The Company's all-tissue Waterlase dental laser systems consist of its flagship Waterlase iPlus, Waterlase Express, and Waterlase MDX. Its soft tissue diode laser systems consist of the Epic X, Epic Hygiene, Epic Q, and Epic 10 diode lasers that perform soft tissue, hygiene, cosmetic procedures, teeth whitening, and provide temporary pain relief. Epic X, and Epic 10 systems feature its 940 nanometer wavelength with patented pulse technology called ComfortPulse.
- Revenue in USD (TTM)48.83m
- Net income in USD-38.26m
- Incorporated1987
- Employees157.00
- LocationBIOLASE Inc27042 Towne Centre Drive, Suite 270FOOTHILL RANCH 92610United StatesUSA
- Phone+1 (949) 361-1200
- Fax+1 (949) 273-6677
- Websitehttps://www.biolase.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nuwellis Inc | 8.90m | -19.93m | 4.73m | 59.00 | -- | 2.01 | -- | 0.5317 | -8.30 | -8.30 | 2.73 | 0.1304 | 0.7076 | 1.55 | 7.04 | 150,762.70 | -143.62 | -98.07 | -216.07 | -122.48 | 57.41 | 55.22 | -202.97 | -230.51 | 0.7092 | -4.75 | 0.00 | -- | 3.76 | 12.14 | -55.78 | -- | 4.61 | -- |
| Bioelectronics Corp | 1.61m | -289.82k | 4.94m | 9.00 | -- | -- | -- | 3.07 | -0.00002 | -0.00002 | 0.00007 | -0.0006 | 6.32 | 9.20 | 14.53 | -- | -113.86 | -383.59 | -- | -- | 49.43 | 51.48 | -18.01 | -143.48 | 0.0099 | -0.4909 | -- | -- | 94.01 | -5.09 | 75.01 | -- | -- | -- |
| Pressure Biosciences Inc | 2.27m | -29.56m | 5.00m | 15.00 | -- | -- | -- | 2.20 | -1.70 | -1.70 | 0.1299 | -1.22 | 1.02 | 2.28 | 9.17 | 151,505.30 | -1,074.63 | -643.54 | -- | -- | 6.89 | 34.75 | -1,050.30 | -798.21 | 0.0185 | -0.4182 | -- | -- | -13.64 | -5.05 | 21.52 | -- | -34.47 | -- |
| Arch Therapeutics Inc | 130.55k | -8.43m | 5.02m | 8.00 | -- | -- | -- | 38.47 | -3.68 | -3.68 | 0.0425 | -2.45 | 0.0833 | 0.0637 | -- | 16,318.75 | -538.25 | -188.28 | -- | -804.63 | 33.37 | -- | -6,458.14 | -26,945.92 | 0.0164 | -1.27 | -- | -- | 383.83 | -- | -32.35 | -- | -21.76 | -- |
| Hawkeye Systems Inc | 0.00 | -804.18k | 5.11m | 44.00 | -- | -- | -- | -- | -0.1186 | -0.1186 | 0.00 | -0.29 | 0.00 | -- | -- | -- | -66.07 | -330.11 | -- | -- | -- | -- | -- | -218.49 | -- | -2.78 | 10.45 | -- | -- | -- | 4.85 | -- | -- | -- |
| Nexalin Technology Inc | 158.86k | -4.94m | 5.21m | 6.00 | -- | 2.24 | -- | 32.77 | -0.6676 | -0.6676 | 0.0215 | 0.3129 | 0.0363 | 0.1778 | 44.01 | 26,476.67 | -112.76 | -- | -139.94 | -- | 82.54 | -- | -3,110.58 | -- | 4.75 | -- | 0.00 | -- | -91.62 | -- | -173.80 | -- | -- | -- |
| ADM Tronics Unlimited Inc | 2.85m | -716.86k | 5.34m | 7.00 | -- | 4.84 | -- | 1.88 | -0.0106 | -0.0106 | 0.0421 | 0.0163 | 0.9772 | 3.85 | 4.25 | -- | -24.62 | -11.45 | -38.81 | -15.77 | 38.45 | 43.73 | -25.19 | -15.28 | 1.24 | -- | 0.2902 | -- | 14.66 | -0.4159 | 93.04 | -- | -- | -- |
| Guided Therapeutics Inc | 82.00k | -3.23m | 5.57m | 4.00 | -- | -- | -- | 67.91 | -0.0623 | -0.0623 | 0.0016 | -0.0721 | 0.0374 | 0.0904 | 11.71 | 20,500.00 | -137.80 | -136.13 | -- | -- | 32.93 | 29.39 | -3,685.37 | -3,666.67 | 0.1138 | -11.13 | -- | -- | 653.85 | 11.45 | 24.40 | -- | -- | -- |
| BIOLASE Inc | 48.83m | -38.26m | 5.70m | 157.00 | -- | -- | -- | 0.1168 | -20.50 | -20.50 | 8.64 | 0.0081 | 1.28 | 2.21 | 9.00 | 311,006.40 | -55.75 | -49.28 | -118.58 | -85.80 | 34.25 | 35.27 | -43.56 | -50.72 | 0.6409 | -5.98 | 0.9812 | -- | 1.45 | 1.27 | -30.39 | -- | 18.63 | -- |
| Predictive Oncology Inc | 1.96m | -14.78m | 5.87m | 34.00 | -- | 1.43 | -- | 2.99 | -3.66 | -3.66 | 0.4853 | 0.9977 | 0.1099 | 1.71 | 4.95 | 57,642.65 | -82.89 | -91.80 | -108.54 | -126.29 | 64.18 | 64.64 | -754.19 | -1,419.99 | 1.35 | -- | 0.0093 | -- | 18.24 | 4.75 | 45.67 | -- | 5.44 | -- |
| Encision Inc | 6.87m | -448.00k | 5.88m | 31.00 | -- | 2.68 | -- | 0.857 | -0.0381 | -0.0381 | 0.5835 | 0.1863 | 1.64 | 1.96 | 7.84 | 221,520.00 | -10.69 | -1.07 | -14.05 | -1.46 | 50.54 | 52.27 | -6.52 | -0.613 | 1.08 | -6.22 | 0.1123 | -- | -4.17 | -3.44 | -393.90 | -- | 12.89 | -- |
| ReShape Lifesciences Inc | 8.34m | -10.92m | 5.98m | 31.00 | -- | 1.32 | -- | 0.7174 | -2.30 | -2.30 | 0.7319 | 0.1933 | 0.6781 | 0.8178 | 4.52 | 268,871.00 | -88.83 | -136.06 | -162.20 | -194.32 | 65.85 | 56.30 | -130.99 | -408.36 | 1.26 | -- | 0.00 | -- | -22.79 | -0.9474 | 75.36 | -- | -49.29 | -- |
| Sharps Technology Inc | 0.00 | -8.71m | 5.99m | 3.00 | -- | 0.8726 | -- | -- | -0.6204 | -0.6204 | 0.00 | 0.4378 | 0.00 | -- | -- | -- | -74.67 | -- | -95.84 | -- | -- | -- | -- | -- | 0.492 | -- | 0.00 | -- | -- | -- | -112.12 | -- | -- | -- |
| Sonendo Inc | 40.19m | -57.74m | 6.05m | 216.00 | -- | 0.2464 | -- | 0.1504 | -0.6125 | -0.5552 | 0.426 | 0.3482 | 0.4448 | 2.07 | 7.58 | 186,055.60 | -63.91 | -- | -78.82 | -- | 27.64 | -- | -143.67 | -- | 2.14 | -10.83 | 0.4695 | -- | 5.30 | -- | -6.78 | -- | -- | -- |
| Fuse Medical Inc | 18.40m | 3.63m | 6.06m | 31.00 | 2.28 | -- | 1.64 | 0.3295 | 0.036 | 0.036 | 0.2307 | -0.0031 | 0.9593 | 0.7018 | 5.75 | 593,671.90 | 18.91 | 0.7504 | 48.45 | 1.35 | 64.95 | 54.98 | 19.72 | 0.6552 | 0.3143 | -1.13 | 1.12 | -- | -8.67 | -6.72 | 295.11 | 34.66 | -- | -- |
| Sigyn Therapeutics Inc | 0.00 | -3.56m | 6.43m | 5.00 | -- | -- | -- | -- | -3.04 | -3.04 | 0.00 | -3.28 | 0.00 | -- | -- | 0.00 | -724.37 | -493.15 | -- | -- | -- | -- | -- | -10,223.96 | 0.0199 | -1.92 | -- | -- | -- | -- | -41.51 | -- | -- | -- |
Data as of Jun 04 2024. Currency figures normalised to BIOLASE Inc's reporting currency: US Dollar USD
5.48%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| S.H.N. Financial Investments Ltd.as of 13 Feb 2024 | 1.19m | 3.66% |
| Virtu Americas LLCas of 31 Mar 2024 | 143.54k | 0.44% |
| Millennium Management LLCas of 31 Mar 2024 | 116.66k | 0.36% |
| HRT Financial LLCas of 31 Mar 2024 | 101.14k | 0.31% |
| XTX Markets LLCas of 31 Mar 2024 | 73.08k | 0.23% |
| RBC Dominion Securities, Inc. (Investment Management)as of 31 Mar 2024 | 50.00k | 0.15% |
| Citadel Securities LLCas of 31 Mar 2024 | 39.83k | 0.12% |
| G1 Execution Services LLCas of 31 Mar 2024 | 36.65k | 0.11% |
| Kellett Wealth Advisors LLCas of 31 Mar 2024 | 19.06k | 0.06% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 10.91k | 0.03% |
More ▼
Data from 31 Mar 2024 - 01 May 2024Source: FactSet Research Systems Inc.
